Yi Bong Gu, Park Ok Kyu, Jeong Myeong Seon, Kwon Seung Hae, Jung Jae In, Lee Seongsoo, Ryoo Sungwoo, Kim Sung Eun, Kim Jin Won, Moon Won-Jin, Park Kyeongsoon
Korea Basic Science Institute Chuncheon Center, Chuncheon, Gangwon 200-701, Republic of Korea; Interdisplinary Graduate Program for BIT Medical Convergence and Department of Biology, College of Natural Sciences, Kangwon National University, Chuncheon, Gangwon 200-701, Republic of Korea.
Korea Basic Science Institute Chuncheon Center, Chuncheon, Gangwon 200-701, Republic of Korea.
Int J Biol Macromol. 2017 Apr;97:181-189. doi: 10.1016/j.ijbiomac.2017.01.037. Epub 2017 Jan 9.
Scavenger receptors (SRs) expressed on the activated macrophages in inflammation sites have been considered as the most interesting and important target biomarker for targeted drug delivery, imaging and therapy. In the present study, we fabricated the scavenger receptor-A (SR-A) targeted-photoactivatable nanoagents (termed as Ce6/DS-DOCA) by entrapping chlorin e6 (Ce6) into the amphiphilic dextran sulfate-deoxycholic acid (DS-DOCA) conjugates via physically hydrophobic interactions. Insoluble Ce6 was easily encapsulated into DS-DOCA nanoparticles by a dialysis method and the loading efficiency was approximately 51.7%. The Ce6/DS-DOCA formed nano-sized self-assembled aggregates (28.8±5.6nm in diameter), confirmed by transmission electron microscope, UV/Vis and fluorescence spectrophotometer. The Ce6/DS-DOCA nanoagents could generate highly reactive singlet oxygen under laser irradiation. Also, in vitro studies showed that they were more specifically taken up by lipopolysaccharide (LPS)-induced activated macrophages (RAW 264.7) via a SR-A-mediated endocytosis, relative to by non-activated macrophages, and notably induced cell death of activated macrophages under laser irradiation. Therefore, SR-A targetable and photoactivatable Ce6/DS-DOCA nanoagents with more selective targeting to the activated macrophages will have great potential for treatment of inflammatory diseases.
炎症部位活化巨噬细胞上表达的清道夫受体(SRs)被认为是靶向药物递送、成像和治疗中最有趣且最重要的靶标生物标志物。在本研究中,我们通过物理疏水相互作用将二氢卟吩e6(Ce6)包裹于两亲性硫酸葡聚糖 - 脱氧胆酸(DS - DOCA)共轭物中,制备了清道夫受体A(SR - A)靶向的光活化纳米制剂(称为Ce6/DS - DOCA)。通过透析法,不溶性的Ce6易于被包裹进DS - DOCA纳米颗粒中,其负载效率约为51.7%。透射电子显微镜、紫外/可见分光光度计和荧光分光光度计证实,Ce6/DS - DOCA形成了纳米尺寸的自组装聚集体(直径为28.8±5.6nm)。Ce6/DS - DOCA纳米制剂在激光照射下可产生高活性单线态氧。此外,体外研究表明,相对于未活化的巨噬细胞,它们通过SR - A介导的内吞作用更特异性地被脂多糖(LPS)诱导活化的巨噬细胞(RAW 264.7)摄取,并且在激光照射下显著诱导活化巨噬细胞的细胞死亡。因此,对活化巨噬细胞具有更高选择性靶向性的SR - A靶向且光活化的Ce6/DS - DOCA纳米制剂在炎症性疾病治疗方面具有巨大潜力。